National
News
Features
Profiles/Interviews
Local Sports
Global
Football
Middle East
Basketball
Africa
Europe
Americas
Asia
Baseball
Cricket
Australasia
Racing
Rugby
Olympics
Yalla Jordan
The Royal wedding
Where to Go
Around Jordan
Cartoon
Business
Economy
Trade & Industry
Entrepreneurship
Opinion & Analysis
Analysis
Opinion
Lifestyle
Good Food
Health
Fashion
Culture & Arts
Travel
Entertainment
Education
Music
Technology
Gaming
Drive
Reviews
Books
Trending
Odd & Bizarre
Property
Weather
Home
National
News
Features
Profiles/Interviews
Local Sports
Global
REGION & WORLD
Middle East
Africa
Europe
Americas
Asia
Australasia
SPORTS
Football
Basketball
Baseball
Cricket
Racing
Rugby
Olympics
Yalla Jordan
The Royal wedding
Where to Go
Around Jordan
Cartoon
Business
Economy
Trade & Industry
Entrepreneurship
Opinion & Analysis
Analysis
Opinion
Lifestyle
Good Food
Health
Fashion
Culture & Arts
Travel
Entertainment
Education
Music
Technology
Gaming
Drive
Reviews
Books
Trending
Odd & Bizarre
Property
Weather
Breaking News:
Comprehensive Traffic Security Plan for the New School Year
Hebrew Media Reports Possible Israeli Delegation to Doha for Gaza Negotiations
Death Toll in Gaza Reaches 62,192 Amid Israeli Aggression
Jordan Foils Infiltration Attempt and Intercepts Drone Carrying Drugs
Jordan Issues First License for Commercial Drone Operator
Trump Temporarily Steps Back from Russia-Ukraine Peace Talks
Gold Prices Fall Ahead of Federal Reserve Policy Signals
Global Oil Prices Rise
Local Gold Price at JD 67.80 per Gram
Dollar Slips Amid Clash Between Trump and Federal Reserve
August 23 2025
12:16 AM
Newsletter
Subscribe
Sign in
My Account
Sign out
#Hikma
S&P upgrades Hikma Pharmaceuticals PLC and its Senior Notes to ‘BBB’ on continued good business momentum; outlook stable
May 11,2025
|
Trade & Industry
Hikma, Celltrion sign monoclonal antibody licensing agreement
Nov 29,2022
|
All
Hikma’s success story: how to revive industry
Oct 15,2022
|
Opinion
HM stresses importance of pharmaceutical sector to economy at Hikma inaugration
Sep 06,2022
|
News
Hikma, Adalvo agree to commercialize allergic Rhinitis
Aug 31,2022
|
All
Hikma, MPP sign licensing agreement for COVID-19 pill
Jan 21,2022
|
All
Hikma to acquire Custopharm for $375 million
Sep 27,2021
|
News
Hikma announces good 2021 start, reiterates full year guidance
May 01,2021
|
All
